European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biopharma company that utilizes a propr...

Related Keywords

United States ,Jeffrey Meckler ,Louie Toma ,Jules Abraham ,European Patent Office ,Nasdaq ,Indaptus Therapeutics Inc ,Company Decoy ,Infections Using Bacteria ,Indaptus Therapeutics ,Private Securities Litigation Reform ,Quarterly Report ,Annual Report ,Relations Contact ,